William Blair & Company
KERX

William Blair & Company’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

William Blair & Company’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-187,900
Closed -$639K – 1840
2018
Q3 		$639K Sell
187,900
-7,000
-4% -$25.2K ﹤0.01% 875
2018
Q2 		$733K Buy
194,900
+6,800
+4% +$33.1K 0.01% 820
2018
Q1 		$769K Hold
188,100
– – 0.01% 779
2017
Q4 		$875K Sell
188,100
-4,300
-2% -$23.7K 0.01% 779
2017
Q3 		$1.37M Buy
192,400
+51,200
+36% +$368K 0.01% 642
2017
Q2 		$1.02M Buy
+141,200
New +$882K 0.01% 751
2015
Q1 		– Sell
-9,000
Closed -$127K – 2230
2014
Q4 		$127K Buy
+9,000
New +$139K ﹤0.01% 2011
2014
Q1 		– Sell
-7,400
Closed -$95K – 2085
2013
Q4 		$95K Buy
7,400
+200
+3% +$2.39K ﹤0.01% 1920
2013
Q3 		$72K Buy
+7,200
New +$64.1K ﹤0.01% 1971

William Blair & Company's KERX Position: Q4 2018 in Review

William Blair & Company sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 187,900 shares — an estimated $639K sold.

William Blair & Company first reported a position in KERX in Q3 2013 and held it in 9 quarters. The position peaked at $1.37M in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • William Blair & Company reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • William Blair & Company sold 187,900 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $639K.
  • William Blair & Company first reported a position in Keryx Biopharmaceuticals Inc in Q3 2013 and held it in 9 quarters.
  • William Blair & Company's Keryx Biopharmaceuticals Inc position peaked at $1.37M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on William Blair & Company's 13F filing for Q4 2018, filed 14 Feb 2019.